Literature DB >> 7942980

Hypocholesterolemia and affective disorders.

C J Glueck1, M Tieger, R Kunkel, T Hamer, T Tracy, J Speirs.   

Abstract

The authors' specific aim was to assess hypocholesterolemia in 203 patients hospitalized because of affective disorders (depression, bipolar disorder, and schizoaffective disorder) compared with 1,595 self-referred subjects in an urban supermarket screening and with 11,864 subjects in the National Health and Nutrition Examination Survey II, a national probability sample. Low plasma cholesterol concentrations (< 160 mg/dL) were much more common in patients with affective disorders (20%) than in urban supermarket screenees (4%, P < or = 0.001) or in the National Health and Nutrition Examination Survey II subjects (10%, P < or = 0.001). When paired with supermarket screenees by age and sex, patients with affective disorders had much lower plasma total cholesterol (P < or = 0.0002), low-density lipoprotein cholesterol (P < or = 0.001), and high-density lipoprotein cholesterol (P < or = 0.0001), and higher triglyceride concentrations (P < or = 0.03). Neither the severity of the affective disorders nor severity-age interactions were associated with plasma cholesterol concentrations (P > 0.1); age and plasma cholesterol were positively associated (P = 0.01). None of the psychoactive drugs had a significant independent association with the patients' low-density lipoprotein cholesterol. Plasma cholesterol in patients hospitalized with affective disorders is shifted markedly downward toward hypocholesterolemic concentrations (< 160 mg/dL). There is no evidence that low plasma cholesterol could cause or worsen affective disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942980     DOI: 10.1097/00000441-199430840-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

1.  Serum lipid levels in seasonal affective disorder.

Authors:  Edda Pjrek; Dietmar Winkler; David W Abramson; Anastasios Konstantinidis; Jürgen Stastny; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-05       Impact factor: 5.270

2.  Lipid trajectories as predictors of depressive symptoms: the Young Finns Study.

Authors:  Marko Elovainio; Laura Pulkki-Råback; Mika Kivimäki; Markus Jokela; Jorma Viikari; Olli T Raitakari; Risto Telama; Liisa Keltikangas-Järvinen
Journal:  Health Psychol       Date:  2010-05       Impact factor: 4.267

Review 3.  Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.

Authors:  P M Moriarty; C A Gibson
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

Review 4.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

5.  Cholesterol and affective morbidity.

Authors:  Jess G Fiedorowicz; Narasimha M Palagummi; Ole Behrendtsen; William H Coryell
Journal:  Psychiatry Res       Date:  2009-12-06       Impact factor: 3.222

6.  Increased health risk in subjects with high self-reported seasonality.

Authors:  Nicolas M Øyane; Reidun Ursin; Ståle Pallesen; Fred Holsten; Bjørn Bjorvatn
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

7.  Cholesterol quandaries: relationship to depression and the suicidal experience.

Authors:  Randy A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2008-03

8.  Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults.

Authors:  M A Beydoun; H A Beydoun; G A Dore; M T Fanelli-Kuczmarski; M K Evans; A B Zonderman
Journal:  Transl Psychiatry       Date:  2015-03-03       Impact factor: 6.222

Review 9.  Depression, mitochondrial bioenergetics, and electroconvulsive therapy: a new approach towards personalized medicine in psychiatric treatment - a short review and current perspective.

Authors:  Alexander Karabatsiakis; Carlos Schönfeldt-Lecuona
Journal:  Transl Psychiatry       Date:  2020-07-09       Impact factor: 6.222

10.  Lipid and Glycemic Profiles in Patients with Bipolar Disorder: Cholesterol Levels Are Reduced in Mania.

Authors:  Laura Fusar-Poli; Andrea Amerio; Patriciu Cimpoesu; Antimo Natale; Virginio Salvi; Guendalina Zappa; Gianluca Serafini; Mario Amore; Eugenio Aguglia; Andrea Aguglia
Journal:  Medicina (Kaunas)       Date:  2020-12-30       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.